Chinook Therapeutics Inc (NASDAQ:KDNY)
| 22.03 Delayed Data As of 3:59pm ET |  -0.19 / -0.86%Today’s Change | 12.41 Today|||52-Week Range 27.44 | -15.92% Year-to-Date |
Institutional investors purchased a net $1.5 million shares of KDNY during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 71.51% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Other institutional | 45.08% |
| Mutual fund holders | 26.43% |
| Individual stakeholders | 14.86% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | FEDERATED GLOBAL INVESTMENT MANA... Bought 867.9 Thousand shares of Chinook Therapeutics Inc |
| 12/31/2022 | ADAGE CAPITAL MANAGEMENT LP Bought 720.2 Thousand shares of Chinook Therapeutics Inc |
| 12/31/2022 | BLACKROCK FUND ADVISORS Bought 543.4 Thousand shares of Chinook Therapeutics Inc |
Top 10 Owners of Chinook Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BlackRock Fund Advisors | 5.55% | 3,550,018 | 77,461,393 | +543,440 | +18.08% |
| Deep Track Capital LP | 4.69% | 3,000,000 | 65,460,000 | 0 | 0.00% |
| The Vanguard Group, Inc. | 4.26% | 2,721,705 | 59,387,603 | +391,513 | +16.80% |
| SSgA Funds Management, Inc. | 4.16% | 2,658,956 | 58,018,420 | +193,237 | +7.84% |
| Octagon Capital Advisors LP | 3.99% | 2,551,703 | 55,678,159 | 0 | 0.00% |
| Baker Bros. Advisors LP | 3.96% | 2,534,102 | 55,294,106 | 0 | 0.00% |
| Suvretta Capital Management LLC | 2.26% | 1,444,830 | 31,526,191 | +54,830 | +3.94% |
| Point72 Asset Management LP | 1.98% | 1,267,660 | 27,660,341 | -1,173,094 | -48.06% |
| Dimensional Fund Advisors LP | 1.94% | 1,238,080 | 27,014,906 | +124,336 | +11.16% |
| Pictet Asset Management SA | 1.82% | 1,166,164 | 25,445,698 | +484,052 | +70.96% |
Top 10 Mutual Funds Holding Chinook Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index... | 2.69% | 1,717,748 | 37,481,261 | +3,865 | +0.23% |
| SPDR S&P Biotech ETF | 2.29% | 1,463,646 | 31,936,756 | -13,020 | -0.88% |
| Candriam Equities L - Biotechnolo... | 1.85% | 1,185,314 | 25,863,551 | 0 | 0.00% |
| iShares Russell 2000 ETF | 1.74% | 1,109,331 | 24,205,602 | -3,510 | -0.32% |
| Vanguard Extended Market Index Fu... | 0.94% | 603,535 | 13,169,134 | +1,448 | +0.24% |
| iShares Russell 2000 Value ETF | 0.80% | 510,760 | 11,144,783 | +1,555 | +0.31% |
| Federated Hermes Kaufmann Fund | 0.70% | 450,000 | 9,819,000 | +450,000 | -- |
| Fidelity Small Cap Index Fund | 0.64% | 408,539 | 8,914,321 | +11,545 | +2.91% |
| Federated Hermes Kaufmann Small C... | 0.63% | 405,000 | 8,837,100 | +405,000 | -- |
| Eventide Healthcare & Life Scienc... | 0.58% | 368,811 | 8,047,456 | +368,811 | -- |